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Abstract 
Background: Allergic rhinitis is the most common form of allergy worldwide. The accuracy of skin testing for allergic 
rhinitis is still debated. Our primary objective was to evaluate the diagnostic accuracy of skin-prick testing for allergic 
rhinitis using the nasal provocation as the reference standard. We also evaluated the diagnostic accuracy of intrader-
mal testing as a secondary objective.
Methods: We searched EBM Reviews from 2005 to March 2015; Embase from 1980 to March 2015; and Ovid 
MEDLINE(R) from 1946 to until March 2015. We included any study with at least 10 subjects including children. We 
excluded non-English studies. We performed data extraction and quality assessment using the QUADAS-2 tool.
Results: We meta-analysed seven studies assessing the accuracy of skin-prick testing using the bivariate random-
effects model, including a total of 430 patients. The pooled estimate for sensitivity and specificity for skin-prick testing 
was 85 and 77 % respectively. We did not pool results for intradermal testing due to few number of studies (n = 4), 
each with very small sample size. Of these, two evaluated the accuracy of intradermal testing in confirming skin-prick 
testing results, with sensitivity ranging from 27 to 50 % and specificity ranging from 60 to 100 %. The other two evalu-
ated the accuracy of intradermal testing as a stand-alone test for diagnosing allergic rhinitis with sensitivity ranging 
from 60 to 79 % and specificity ranging from 68 to 69 %.
Conclusions: Findings from this review suggest that skin-prick testing is accurate in discriminating subjects with or 
without allergic rhinitis.
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Background
Allergic rhinitis is a collection of symptoms that develop 
when the immune system becomes sensitized and over-
reacts to air-borne allergens [1]. It is the most common 
allergic disorder worldwide, [2] and one among the lead-
ing chronic conditions affecting both children and adults 
[3]. The global prevalence of allergic rhinitis is between 
10 and 30 % for adults and as high as 40 % for children [4, 
5]. Symptoms of allergic rhinitis usually develop before 
age 20  years, [6] and peak at age 20–40  years, before 
gradually declining [7].
The diagnosis of allergic rhinitis is often made on the 
basis of clinical characteristics and response to phar-
macotherapy [7]. Evidence of sensitization to a known 
allergen usually involves a combination of skin or blood 
testing and patient’s exposure history [8]. Because of 
ease of administration and being less invasive, skin-prick 
testing is recommended for diagnosis of allergic rhi-
nitis, followed by intradermal testing to confirm nega-
tive skin-prick testing results [9]. There is no universally 
accepted “gold standard” for detecting allergic rhinitis, 
although in research studies, nasal provocation is often 
used as the reference standard. There seems to be no 
consensus among researchers on the diagnostic accuracy 
of skin testing for allergies [10–12], including allergic 
rhinitis [13–15]. The variability in the accuracy of these 
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tests across studies can be explained by lack of stand-
ardization, stability and composition of allergens, the 
testing device, the patient population, or the quality of 
study design. However, we are not aware of any system-
atic review that has evaluated the diagnostic accuracy of 
skin testing for allergic rhinitis across a range of studies. 
To address this issue, we conducted a systematic review 
and meta-analysis of published studies on the diagnostic 
accuracy of skin-prick testing in children or adults with 
suspected symptoms of allergic rhinitis. As a second-
ary analysis we also evaluated the diagnostic accuracy of 
intradermal testing for the same group of patients.
Review
Methods
We conducted and reported this review according to 
published guidelines using a pre-specified protocol [16].
Eligibility criteria
We included any study that reported both sensitivity 
and specificity of skin-prick testing in at least 10 sub-
jects including adults, children or both with allergic rhi-
nitis using nasal provocation as the reference standard. 
We included full text papers and abstracts published in 
English language. We excluded studies enrolling sub-
jects with known allergic status (commonly referred to as 
“case–control” designs in the diagnostic accuracy litera-
ture), and studies that did not include nasal provocation 
as the reference standard.
Search strategy
We performed a literature search with the help of medi-
cal librarians on April 24, 2015, using All Ovid MED-
LINE (from 1946 to present), Embase (from 1980 to 
present), Cochrane Database of Systematic Reviews 
(from 2005-present), Database of Abstracts of Reviews 
of Effects (from 1991-present), CRD Health Technology 
Assessment Database (from 2001-present), Cochrane 
Central Register of Controlled Trials (1991-present), and 
NHS Economic Evaluation Database (from 1995-pre-
sent). The search strategy included a combination of key 
words and MeSH terms and was adapted for each data-
base to account for differences in indexing. We limited 
our search to English language. We also searched gray 
literature sources and conference abstracts. Appendix 1 
provides details on the search strategies used. We also 
examined reference lists for any additional relevant stud-
ies not identified through the search.
Study selection, data abstraction and analysis
We screened titles and abstract (CK, IN) and obtained 
full texts for studies that met the eligibility criteria. We 
extracted estimates for sensitivity, specificity, and sample 
size from all eligible studies. We also computed sensitiv-
ity and/or specificity for studies that did not report these 
estimates but provided sufficient information for their 
derivation. We constructed forest plots to assess hetero-
geneity in test accuracy across studies. In case of substan-
tial heterogeneity, we proceeded with a subgroup analysis 
to determine the reason for inconsistency. When homo-
geneity assumption was deemed appropriate, we pooled 
studies using the bivariate approach [17]. The pooled 
results were presented on a summary receiver operat-
ing characteristic curve (sROC), which included a 95  % 
confidence ellipse. When homogeneity assumption failed 
to hold, we presented sensitivity and specificity sepa-
rately for each study. The logit transformation was used 
for the calculation of study specific confidence intervals 
to account for asymmetry in the distribution of sensitiv-
ity and specificity. When estimates were on, or too close 
to the boundary of the parameter space (i.e., values for 
sensitivity or specificity were equal to, or approximately 
equal to 0 or 100  %), a continuity correction factor of 
1 % was applied. All analyses were performed using the 
MADA package in R version 3.0.2.
Quality of evidence
The quality of evidence for each bivariate outcome within 
studies was examined according to the quality assess-
ment of diagnostic accuracy studies (QUADAS-2) [18]. 
This tool consists of four key domains: patient selection, 
index test, reference standard, and flow and timing.
Results
Study selection
One reviewer (CK) screened and evaluated 2360 cita-
tions and assessed 56 full text articles for eligibility. An 
unbiased sample of 374 citations were screened by a sec-
ond reviewer (IN) using the method of Nevis et al. [19]. 
The chance-corrected agreement for titles and abstracts 
was good (estimated kappa = 75 %; 95 % CI 50–100 %). 
We resolved disagreements by consensus. Of the 56 full 
text articles, we excluded 42 as they were not relevant, 
three articles had insufficient information on outcomes 
and three were case control studies. Figure 1 summarizes 
the selection process. Eight articles were eligible to be 
included in the systematic review [15, 20–25]. Only seven 
of the eight articles were included in the meta-analysis 
because one study restricted their allergen to alternaria 
that was not evaluated by any of the other eligible studies 
in this review, and whose findings deviated substantially 
from the remaining studies [14].
Description of studies, methods and participants
Eight studies from four countries focused our primary 
research question (i.e., accuracy of skin prick testing), 
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recruiting a total of 609 patients (range 37–141) (Table 1). 
Four of the included studies [14, 15, 20, 24] focused on 
secondary research question (i.e., accuracy of intrader-
mal testing) (Table 2). Most studies were done in North 
America (n = 5), followed by one study each from Italy, 
Sweden and United Kingdom. All study participants were 
recruited using non-random sampling approaches. Five 
studies recruited participants in a clinical setting [15, 21–
23, 25]. Most (n = 11) studies reported age of the study 
population, ranging from 9 to 70  years. The percentage 
of males ranged from 18 to 70 %. Seven of eight provided 
information on cut-off point for positive skin prick testing 
[20–25]. Five studies evaluated a single allergen, of which 
two evaluated cat allergens [24, 25] and the remaining 
three evaluated Timothy grass, ragweed and alternaria 
each [14, 15, 20]. Three studies evaluated two or more 
allergens [21–23] which included grass, mugwort, birch, 
pellitory, timothy, sweet vernal, cocksfoot, meadow fes-
cue, rye, meadow and dermatophagoides pteronyssinus 
(Table 1). The most frequently evaluated allergen extract 
was timothy grass, reported in three studies [20, 22, 23] 
and cat, reported in two studies [24, 25].
Primary analysis: diagnostic accuracy of skin‑prick testing
We conducted a meta-analysis of studies reporting sen-
sitivity and specificity of skin-prick testing. The pooled 
estimate of sensitivity and specificity for this test was 
88.4 and 77.1 % respectively (Fig. 2). We also conducted 
a sensitivity analysis by including in the meta-analysis, 
the study that tested for alternaria [14]. Inclusion of this 
study did not significantly alter the estimates for accu-
racy. The pooled estimate for sensitivity and specificity 
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Fig. 1 PRISMA flow diagram of studies identified, included and excluded
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changed to 85.0 and 77.3 % respectively (Fig. 3). The for-
est plots for heterogeneity are presented in Figs. 4 and 5.
Five studies that evaluated the accuracy of skin-prick 
testing [14, 15, 20, 24, 25] restricted the analysis to single-
allergen extracts. The sensitivity and specificity ranged 
from 79 % (95 % CI 66–88 %) to 100 % (82–100 %) and 
79 % (95 % CI 66–88 %) to 91 % (76–97 %) respectively, 
excluding Krouse et al. [14]. When Krouse et al. [14] was 
included, the minimum values for sensitivity and speci-
ficity were altered to 42 % (95 % CI 23–64 %) and 64 % 
(95 % CI 45–80 %) respectively.
Three studies that evaluated the accuracy of skin-prick 
testing examined multiple-allergen extracts [21–23]. The 
reported sensitivity ranged from 68 % (57–78 %) to 97 % 
(86–100  %), and specificity ranged from 70  % (95  % CI 
54–86 %) to 84 % (95 % CI 74–91 %) respectively.
Secondary analysis: diagnostic accuracy of intradermal 
testing
We conducted a systematic review of four studies that 
reported sensitivity and specificity of intradermal test-
ing. When intradermal testing was used to confirm 
negative skin-prick testing results, the estimates for 
sensitivity ranged from 27 % (95 % CI 10–57 %) to 50 % 
(sample size was too small for estimation of CI using 
asymptotic-based statistical tests) and those for specific-
ity ranged from 69 % (95 % CI 51–83 %) to 100 % (95 % 
CI 83–100 %). When the test was evaluated as a stand-
alone tool for diagnosing allergic rhinitis, the estimate for 
sensitivity was between 60 % (95 % CI 31–83 %) and 79 % 
(95 % CI 63–90 %), and that for specificity was 68 % (95 % 
CI 49–82  %). All four studies [14, 15, 20, 24] restricted 
the analysis to single-allergen extracts.
Table 2 Characteristics of studies reporting secondary outcome (intradermal testing)
NR not reported
a Of the size of negative control






















Krouse et al. [14] USA Hospital 37 NR NR (18–70) 2 19 ≥3a 50.0 100.0 Timothy 
grass
Krouse et al. [14] USA Hospital 44 NR NR (18–70) 11 16 ≥3a 27.0 69.0 Alternaria
Gungor et al. [15] USA Unclear 62 NR ≥18 34 28 ≥2 79.4 67.9 Ragweed
Wood et al. [24] USA Hospital 120 22 (18) 32 (18–65) 10 29 ≥6 60.0 68.9 Cat
Fig. 2 Summary receiver operating characteristic curve (sROC) of 
seven studies evaluating the accuracy of skin-testing for allergic 
rhinitis, plotted using a bivariate normal distribution model. Estimate 
of the pooled pair of sensitivity and specificity is 88.4 and 77.1 %
Fig. 3 Summary receiver operating characteristic curve (sROC) 
showing the sensitivity of results for the accuracy of skin-testing for 
allergic rhinitis, when we include Krouse et al. [14]. Estimate of the 
pooled pair of sensitivity and specificity only fluctuates a little to 85.0 
and 77.3 %
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Risk of bias and applicability concerns
We summarize assessment of risk of bias in Figs. 6, 7 and 
8. For skin-prick testing the risk of bias was “unclear” in 
five studies [15, 22–25]. For intradermal testing the risk 
of bias was “high” in one study, [14] and “unknown” in 
two studies [15, 25]. Applicability concerns were “high” in 
two studies [14, 20].
We used Fig. 8 to evaluate the potential for heteroge-
neity in estimates for the accuracy of skin-prick testing. 
The inclusion of Krouse et al. [14] introduced a discern-
ible heterogeneity across studies. Specifically, the 95  % 
confidence (CI) for sensitivity barely overlapped with 
CIs of other studies, and its inclusion swayed the corre-
lation between sensitivity and specificity toward a posi-
tive value—violating a requirement for meta-analysis of 
diagnostic accuracy studies that the correlation should be 
non-positive for homogeneity assumption to hold. When 
this study was removed from the analysis, the negative 
correlation was observed (Fig. 5).
Five studies either did not report [15] or use [15, 22–24] 
a 3 mm cut-off value for the wheal size diameter recom-
mended by the American Academy of Allergy, Asthma 
and Immunology (AAAAI) and the American College of 
Allergy, Asthma, and Immunology (ACAAI) [9]. Given 
the relation between the cut-off value and sensitivity and 
specificity, and because a 3 mm cut-off value might not 
be optimal in all settings, [26] we classified these stud-
ies as “unclear-risk of bias”. Moreover, the sample size for 
two studies evaluating the accuracy of intradermal test-
ing [14, 20] was too small, calling into question whether 
Fig. 4 Forest plots for studies evaluating the accuracy of skin prick tests. Estimates from Krouse et al. [14]a deviate considerably from the rest (its 
inclusion attenuates the negative correlation between sensitivity and specificity)
Fig. 5 Forest plots for studies evaluating the accuracy of skin prick tests. Krouse et al. [14]a is excluded
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findings from these studies apply to the majority of sus-
pected allergic rhinitis patients presenting in clinics. We 
classified both studies as “high-risk of bias”.
Discussion
Findings from this review suggest that skin-prick testing 
is reasonably accurate in identifying patients with sus-
pected symptoms of allergic rhinitis. The level of accu-
racy reported in studies eligible for meta-analysis ranged 
from sensitivity of 68 to 100 % and specificity of 70 to 91 %. 
Although we could not establish the source of heteroge-
neity in testing accuracy across studies, several factors 
that influence accuracy of skin-prick testing have been 
reported in the literature [9, 27]. These include skill of the 
tester, the testing device, colour of the skin, skin reactivity 
on the day of testing, potency, and stability of test reagents.
To our knowledge this is the first systematic review 
and meta-analysis to evaluate the accuracy of skin-prick 
testing. Given lack of consensus among researchers and 
health practitioners on the performance of this test, find-
ings from this review broaden our knowledge on the 
accuracy of this test across a large body of evidence. This 
is especially important given that effectiveness of inter-
vention such as immunotherapy, avoidance, or pharma-
cotherapy largely depends on the correct diagnosis. Thus 
proper diagnosis can alleviate financial burden and loss 


































































































































Gungor et al (2004) + ? + + + + + +
Krouse et al (2004) b + + + + + + + +
Pastorello et al (1988) + + + + + + + +
Pepys et al (1975) ? ? + + + + + +
Petersson et al (1986) + ? + + + + + +
Wood et al (1999) + ? + + + + + +
Zarei et al (2004) ? + + + + + + +
- High ? Unclear + Low
Risk of bias Applicability concerns
Fig. 6 Reviewer’s judgment about the risk of bias in each included 
study that assessed the accuracy of skin-prick testing. See Appendix 


































































Krouse et al (2004) b - + + + - + + +
Krouse et al (2004) a + + + + - + + +
Gungor et al (2004) + ? + + + + + +
Wood et al (1999) + ? + + + + + +
- High ? Unclear + Low
Risk of bias Applicability concerns
Fig. 7 Reviewer’s judgment about the risk of bias in each included 
study that assessed the accuracy of intradermal testing. See Appendix 
2 for a detail explanation of domains for risk of bias and applicability 
concern
Fig. 8 Methodological quality of the included studies. See Appendix 2 for a detail explanation of domains for risk of bias and applicability concern
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Although there are no restrictions on age limits for 
skin-prick testing, literature suggests that skin reac-
tion diminishes for young children [28]. That is, a 3 mm 
threshold for wheal size diameter is likely to yield a high 
rate of false positives in this group of patients. However, 
we were unable to assess the accuracy of skin-prick test-
ing in children younger than 9 years due to the fact mini-
mum age for eligible studies for this review was 9 years.
It should be noted that a 3 mm cutoff criteria recom-
mended in guidelines is mainly based on reproducibil-
ity in relation to nasal provocation rather than clinical 
relevance [29]. That is, larger wheal sizes may predict a 
positive response to nasal provocation but not necessar-
ily severity of clinical symptoms. The extent of agreement 
between wheal size and clinical symptoms may depend 
on population characteristics and allergen extracts.
We note the following limitations. First, we were una-
ble to determine the degree of accuracy of intradermal 
testing because of the limitations in the four included 
studies. Hence, well designed methodologically rigor-
ous studies are required to firmly establish the accuracy 
of intradermal testing. Second, we used nasal provoca-
tion as the reference standard. However, this test may 
not always represent the natural exposure to allergens. 
Despite this limitation, nasal provocation is still con-
sidered as the best “gold standard” available by several 
guidelines. Finally, there was a substantial variation in 
allergen extracts among studies. Nonetheless, skin-prick 
testing results remained fairly accurate regardless of the 
type of extracts.
Conclusions
In conclusion this review supports findings from several 
studies that skin-prick testing is accurate for diagnos-
ing patients with allergic rhinitis. Several factors have 
been reported to influence the accuracy of prick testing, 
including skill of the tester, the testing device, color of the 
skin, skin reactivity on the day of testing, potency, and 
stability of test reagents. We were unable to determine 
the degree of accuracy of intradermal testing because 
of the limitations in the four included studies. Well-
designed methodologically rigorous studies are required 
to firmly establish the accuracy of allergy skin testing and 
especially intradermal testing.
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Appendix 1: Search strategy
Database: EBM Reviews—Cochrane Central Register 
of Controlled Trials <March 2015>, EBM Reviews—
Cochrane Database of Systematic Reviews <2005 to 
March 2015>, EBM Reviews—Database of Abstracts of 
Reviews of Effects <1st Quarter 2015>, EBM Reviews—
Health Technology Assessment <1st Quarter 2015>, 
EBM Reviews—NHS Economic Evaluation Database <1st 
Quarter 2015>, Embase <1980 to 2015 Week 16>, All 
Ovid MEDLINE(R) <1946 to Present>
Appendix 2
See Table 3.
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Search Strategy: 
-------------------------------------------------------------------------------- 
1     exp Rhinis/ (95436) 
2     (rhini* or rhinosinusi* or poll?nosis or hay fever or hayfever or ((seasonal or inhalant* or respirat*) adj3 
allerg*)).tw. (85040) 
3     (grass* or tree or trees or pollen$1).tw. (261672) 
4     or/1-3 (372633) 
5     Skin Tests/ (64076) 
6     exp Intradermal Tests/ (6027) 
7     (((test or tests or tesng) adj3 (skin or prick or passive transfer or intradermal or intercutaneous or 
epicutaneous or percutaneous or allerg* or provocat*)) or SPT or SPTs or IDST or IDSTs).tw. (95579) 
8     Bronchial Provocaon Tests/ (12348) 
9     Nasal Provocaon Tests/ (2731) 
10     ((allerg* or provocat* or nasal or inhalant*) adj3 challenge*).tw. (12619) 
11     Radioallergosorbent Test/ (9842) 
12     (radioallergosorbent* or radioimmunosorbent* or RAST or RASTs).tw. (9708) 
13     or/5-12 (158479) 
14     "Sensivity and Specificity"/ (516790) 
15     "Predicve Value of Tests"/ (225688) 
16     likelihood funcons/ (131637) 
17     False Posive Reacon/ (67227) 
18     False Negave Reacon/ (58551) 
19     (sensivit* or specificit* or accurac* or validit* or valida* or predicve value* or PPV or NPV or likelihood 
rao* or ROC curve* or AUC or (false adj posive*) or (false adj negave*)).tw. (3141298) 
20     gold standard.ab. (96368) 
21     or/14-20 (3658119) 
22     4 and 13 and 21 (5172) 
23     (Comment or Editorial or Leer or Congresses).pt. (2809062) 
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24     22 not 23 (5128) 
25     24 use pmoz,cctr,coch,dare,clhta,cleed (2434) 
26     exp Rhinis/ (95436) 
27     (rhini* or rhinosinusi* or poll?nosis or hay fever or hayfever or ((seasonal or inhalant* or respirat*) adj3 
allerg*)).tw. (85040) 
28     (grass* or tree or trees or pollen$1).tw. (261672) 
29     or/26-28 (372633) 
30     Allergy Test/ (3288) 
31     Skin Test/ (64067) 
32     Prick Test/ (14084) 
33     Intracutaneous Test/ (2696) 
34     (((test or tests or tesng) adj3 (skin or prick or passive transfer or intradermal or intercutaneous or 
epicutaneous or percutaneous or allerg* or provocat*)) or SPT or SPTs or IDST or IDSTs).tw. (95579) 
35     provocaon test/ (24466) 
36     nose provocaon test/ (919) 
37     ((allerg* or provocat* or nasal or inhalant*) adj3 challenge*).tw. (12619) 
38     Radioallergosorbent Test/ (9842) 
39     (radioallergosorbent* or radioimmunosorbent* or RAST or RASTs).tw. (9708) 
40     or/30-39 (168806) 
41     "sensivity and specificity"/ (516790) 
42     Diagnosc Accuracy/ (188623) 
43     Diagnosc Test Accuracy Study/ (32579) 
44     (sensivit* or specificit* or accurac* or validit* or valida* or predicve value* or PPV or NPV or likelihood 
rao* or ROC curve* or AUC or (false adj posive*) or (false adj negave*)).tw. (3141298) 
45     gold standard.ab. (96368) 
46     or/41-45 (3492743) 
47     29 and 40 and 46 (5134) 
48     (Comment or Editorial or Leer or Conference abstract).pt. (4558513) 
49     47 not 48 (4433) 
50     49 use emez (2235) 
51     25 or 50 (4669) 
52     limit 
53     remo




 not valid in C
) 
DSR,DARE; records were retained] (3913) 
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